Raleigh, NC, United States of America

James L Kelley

This inventor holds 19 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Pharmaceutical Compounds. Top assignees: Burroughs Wellcome Co., Glaxo Wellcome Inc., Krenitsky Pharmaceuticals, Inc.. Active years: 1989-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James L Kelley. Retrieved from https://idiyas.com/inventor/james-l-kelley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 94.7


Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 181(Granted Patents)


Location History:

  • Cupertino, CA (US) (1989)
  • Raleigh, NC (US) (1989 - 2010)

Company Filing History:


Years Active: 1989-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Compounds
Neurotrophic Activity
Bicyclic Amides
Pyrimidine Derivatives
Heterocyclic Compounds
Triazolopyridine
Amine-Arylsulfonamide
Pharmacologically Active
Muscle Relaxants
Neurodegenerative Disorders
Central Nervous System
Glutamic Acids
19 patents (USPTO):Explore Patents

Title: James L. Kelley: Innovator in Neurotherapeutics from Raleigh, NC

Introduction: James L. Kelley is a notable inventor based in Raleigh, North Carolina, known for his significant contributions to the field of neurotherapeutics. With a remarkable portfolio of 19 patents, Kelley's work primarily focuses on developing novel compounds that address various neurological disorders.

Latest Patents: Among his most recent innovations are therapeutic amine-arylsulfonamide conjugate compounds, which represent a significant advancement in pharmaceutical formulations. Additionally, he has developed substituted 5-alkynyl pyrimidines, which have shown promising neurotrophic activity. These compounds are particularly important in the treatment of neurodegenerative disorders such as Alzheimer's disease, age-related cognitive decline, nerve injuries, and seizure disorders like epilepsy. His inventions not only contribute to scientific research but also pave the way for effective therapeutic solutions.

Career Highlights: Kelley's career is marked by his associations with prominent pharmaceutical companies, including Burroughs Wellcome Co. and Glaxo Wellcome Inc. Through his work in these organizations, he has played a pivotal role in researching and innovating neurotherapeutic agents that are crucial for patient care.

Collaborations: Throughout his professional journey, Kelley has collaborated with distinguished colleagues such as David Lee Musso and Thomas A. Krenitsky. These partnerships have enriched his innovative process and fostered the development of groundbreaking therapies in neurology.

Conclusion: James L. Kelley's contributions to the field of neurotherapeutics exemplify the impact of dedicated invention and research on health care. His patents not only reflect his innovative spirit but also underline his commitment to improving the lives of those affected by neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…